CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Receives Consensus Recommendation of “Hold” from Analysts

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) has earned a consensus recommendation of “Hold” from the six analysts that are currently covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $117.00.

A number of equities research analysts have recently weighed in on the company. Jefferies Financial Group lowered CochLear to a “hold” rating in a research note on Wednesday. UBS Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. Royal Bank Of Canada downgraded CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research note on Thursday, July 16th. Finally, Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd.

CochLear Trading Down 0.7%

Shares of CHEOY opened at $41.44 on Wednesday. CochLear has a 12 month low of $31.82 and a 12 month high of $105.60. The stock has a fifty day moving average price of $38.46 and a 200-day moving average price of $57.93.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.